Jonathan Moreno

Medicine & Life Sciences

1. Action Potentials 40%
2. Amiodarone 6%
3. Anti-Arrhythmia Agents 17%
4. Calcium 10%
5. Cardiac Arrhythmias 100%
6. Cardiac Electrophysiology 22%
7. Cardiac Myocytes 13%
8. Cell Membrane 5%
9. Cloud Computing 26%
10. Computer Simulation 51%
11. Datasets 19%
12. Distillation 7%
13. Drug Interactions 23%
14. Drug Repositioning 21%
15. Drug Therapy 9%
16. Drug-Related Side Effects and Adverse Reactions 19%
17. Electrophysiology 26%
18. Flecainide 32%
19. Foot 6%
20. Genetic Variation 15%
21. Heart 15%
22. Heart Failure 26%
23. Heart-Assist Devices 18%
24. Hypertrophic Cardiomyopathy 17%
25. indium arsenide 24%
26. Induced Pluripotent Stem Cells 17%
27. Ion Channels 66%
28. Kinetics 41%
29. Lidocaine 15%
30. Long QT Syndrome 20%
31. Long QT syndrome type 3 41%
32. Membranes 9%
33. Mexiletine 40%
34. Mutation 5%
35. Myocardium 21%
36. Pharmaceutical Preparations 28%
37. Pharmacology 27%
38. Polymorphic catecholergic ventricular tachycardia 24%
39. Potassium 7%
40. Precision Medicine 16%
41. Preclinical Drug Evaluations 5%
42. Pulmonary Artery 8%
43. Purkinje Cells 11%
44. Ranolazine 34%
45. Sodium 10%
46. Sodium Channels 21%
47. Software 7%
48. Theoretical Models 7%
49. Therapeutics 11%
50. Voltage-Gated Sodium Channels 7%